Mental health issues, such as depression and substance use, often peak during the holidays, but research has shown that just ...

FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in ...

New CDC data shows that in a survey, 24% of adults said they had pain most days or every day during the past three months.

The FDA has approved cosibelimab, a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer. It is the first and only PD-L1 blocker approved to treat ...

Does your family make you sick at the holidays? We’re not just talking about catching a bug. It’s the emotional toll, which ...

COVID-19 continues to retreat from being a top cause of death in the U.S., and in turn, life expectancy last year rebounded further toward pre-pandemic longevity.

The FDA has approved a new drug called ensartinib for adults with a type of lung cancer called ALK-positive non-small-cell lung cancer (NSCLC).